pISSN 1976-2283
eISSN 2005-1212

Download original image
Fig. 1. Serial changes in serum total (A), low-density lipoprotein (LDL)-cholesterol (B), and high-density lipoprotein (HDL)-cholesterol (C) levels after the initiation of combination therapy with daclatasvir and asunaprevir in hepatitis C virus patients. p-values compared to week 0 of treatment.

FU, follow-up. *p<0.05, p<0.01, p<0.001, §p<0.0001, and determined using the Kruskal-Wallis test followed by Dunn’s multiple comparison test.

Gut and Liver 2018;12:201~207 https://doi.org/10.5009/gnl17179
© Gut and Liver